AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
WHAT IS THE ROLE OF ERYTHROPOIETIN IN PATIENTS WITH SOLID TUMORS
Authors: MARAVEYAS A PETTENGELL R
Citation: A. Maraveyas et R. Pettengell, WHAT IS THE ROLE OF ERYTHROPOIETIN IN PATIENTS WITH SOLID TUMORS, Annals of oncology, 9(3), 1998, pp. 239-241
RANDOMIZED COMPARISON OF PROGENITOR-CELL MOBILIZATION USING CHEMOTHERAPY, STEM-CELL FACTOR, AND FILGRASTIM OR CHEMOTHERAPY PLUS FILGRASTIM ALONE IN PATIENTS WITH OVARIAN-CANCER
Authors: WEAVER A CHANG J WRIGLEY E DEWYNTER E WOLL PJ LIND M JENKINS B GILL C WILKINSON PM PETTENGELL R RADFORD JA COLLINS CD DEXTER TM TESTA NG CROWTHER D
Citation: A. Weaver et al., RANDOMIZED COMPARISON OF PROGENITOR-CELL MOBILIZATION USING CHEMOTHERAPY, STEM-CELL FACTOR, AND FILGRASTIM OR CHEMOTHERAPY PLUS FILGRASTIM ALONE IN PATIENTS WITH OVARIAN-CANCER, Journal of clinical oncology, 16(8), 1998, pp. 2601-2612
IMMUNOTHERAPY OF RECURRENT FOLLICULAR LYMPHOMA (FL) WITH RITUXIMAB (IDEC-C2B8) - PRELIMINARY-RESULTS OF AN ONGOING UK MULTICENTER TRIAL
Authors: FORAN JM ROHATINER AZS CUNNINGHAM D POPESCU R GOLDSTONE AH SWEETENHAM J JOHNSON P BESSELL E PETTENGELL R HANCOCK B LISTER TA
Citation: Jm. Foran et al., IMMUNOTHERAPY OF RECURRENT FOLLICULAR LYMPHOMA (FL) WITH RITUXIMAB (IDEC-C2B8) - PRELIMINARY-RESULTS OF AN ONGOING UK MULTICENTER TRIAL, British Journal of Haematology, 102(1), 1998, pp. 243-243
RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) FOLLOWING HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE IN HIGH-GRADE NON-HODGKINS-LYMPHOMA - CLINICAL BENEFITS AT NO EXTRA COST
Authors: LEE SM RADFORD JA DOBSON L HUQ T RYDER WDJ PETTENGELL R MORGENSTERN GR SCARFFE JH CROWTHER D
Citation: Sm. Lee et al., RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) FOLLOWING HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE IN HIGH-GRADE NON-HODGKINS-LYMPHOMA - CLINICAL BENEFITS AT NO EXTRA COST, British Journal of Cancer, 77(8), 1998, pp. 1294-1299
INTERFERONS IN ONCOLOGY
Authors: WOLL PJ PETTENGELL R
Citation: Pj. Woll et R. Pettengell, INTERFERONS IN ONCOLOGY, British journal of clinical practice, 51(2), 1997, pp. 111-115
TELOMERASE REGULATION, CELL-CYCLE, AND TELOMERE STABILITY IN PRIMITIVE HEMATOPOIETIC-CELLS
Authors: ENGELHARDT M KUMAR R ALBANELL J PETTENGELL R HAN W MOORE MAS
Citation: M. Engelhardt et al., TELOMERASE REGULATION, CELL-CYCLE, AND TELOMERE STABILITY IN PRIMITIVE HEMATOPOIETIC-CELLS, Blood, 90(1), 1997, pp. 182-193
SURVIVAL BENEFIT FRONT HIGH-DOSE THERAPY WITH AUTOLOGOUS BLOOD PROGENITOR-CELL TRANSPLANTATION IN POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA
Authors: PETTENGELL R RADFORD JA MORGENSTERN GR SCARFFE JH HARRIS M WOLL PJ DEAKIN DP RYDER D WILKINSON PM CROWTHER D
Citation: R. Pettengell et al., SURVIVAL BENEFIT FRONT HIGH-DOSE THERAPY WITH AUTOLOGOUS BLOOD PROGENITOR-CELL TRANSPLANTATION IN POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 14(2), 1996, pp. 586-592
EX-VIVO STEM AND PROGENITOR-CELL EXPANSION STRATEGIES
Authors: MOORE MAS PETTENGELL R ENGELHARDT M FREY B SHAPIRO F
Citation: Mas. Moore et al., EX-VIVO STEM AND PROGENITOR-CELL EXPANSION STRATEGIES, Experimental hematology, 24(9), 1996, pp. 32-32
HIGH-DOSE THERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: PETTENGELL R
Citation: R. Pettengell, HIGH-DOSE THERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA, British Journal of Hospital Medicine, 56(10), 1996, pp. 521-524
THE EFFECT OF THE GM-CSF IL-3 FUSION PROTEIN PIXY321 ON BONE-MARROW AND CIRCULATING HEMATOPOIETIC-CELLS OF PREVIOUSLY UNTREATED PATIENTS WITH CANCER/
Authors: GHIELMINI M PETTENGELL R COUTINHO LH TESTA N CROWTHER D
Citation: M. Ghielmini et al., THE EFFECT OF THE GM-CSF IL-3 FUSION PROTEIN PIXY321 ON BONE-MARROW AND CIRCULATING HEMATOPOIETIC-CELLS OF PREVIOUSLY UNTREATED PATIENTS WITH CANCER/, British Journal of Haematology, 93(1), 1996, pp. 6-12
A STUDY OF OVARIAN-CANCER PATIENTS TREATED WITH DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED WITH PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM AND CYCLOPHOSPHAMIDE
Authors: WEAVER A WRIGLEY E WATSON A CHANG J COLLINS CD JENKINS B GILL C PETTENGELL R DEXTER TM TESTA NG CROWTHER D
Citation: A. Weaver et al., A STUDY OF OVARIAN-CANCER PATIENTS TREATED WITH DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED WITH PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM AND CYCLOPHOSPHAMIDE, British Journal of Cancer, 74(11), 1996, pp. 1821-1827
BIOLOGY OF BLOOD PROGENITOR CELLS USED IN TRANSPLANTATION
Authors: PETTENGELL R TESTA NG
Citation: R. Pettengell et Ng. Testa, BIOLOGY OF BLOOD PROGENITOR CELLS USED IN TRANSPLANTATION, International journal of hematology, 61(1), 1995, pp. 1-15
EXPANDING THE ROLE OF BLOOD PROGENITOR CELLS
Authors: PETTENGELL R
Citation: R. Pettengell, EXPANDING THE ROLE OF BLOOD PROGENITOR CELLS, Annals of oncology, 6(8), 1995, pp. 759-767
PRACTICAL APPLICATIONS FOR PERIPHERAL-BLOOD PROGENITOR CELLS IN THE TREATMENT OF LYMPHOMAS AND SOLID TUMORS
Authors: PETTENGELL R
Citation: R. Pettengell, PRACTICAL APPLICATIONS FOR PERIPHERAL-BLOOD PROGENITOR CELLS IN THE TREATMENT OF LYMPHOMAS AND SOLID TUMORS, Annals of oncology, 6, 1995, pp. 9-12
MULTICYCLIC, DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED BY SEQUENTIAL REINFUSION OF HEMATOPOIETIC PROGENITORS IN WHOLE-BLOOD
Authors: PETTENGELL R WOLL PJ THATCHER N DEXTER TM TESTA NG
Citation: R. Pettengell et al., MULTICYCLIC, DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED BY SEQUENTIAL REINFUSION OF HEMATOPOIETIC PROGENITORS IN WHOLE-BLOOD, Journal of clinical oncology, 13(1), 1995, pp. 148-156
TIME-COURSE OF THE RECOVERY OF CELLULAR IMMUNE FUNCTION AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR HIGH-GRADE NON-HODGKINS-LYMPHOMA
Authors: SCHEID C PETTENGELL R GHIELMINI M RADFORD JA MORGENSTERN GR STERN PL CROWTHER D
Citation: C. Scheid et al., TIME-COURSE OF THE RECOVERY OF CELLULAR IMMUNE FUNCTION AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR HIGH-GRADE NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 15(6), 1995, pp. 901-906
EFFECTS OF INTERLEUKIN-6 ON MOBILIZATION OF PRIMITIVE HEMATOPOIETIC-CELLS INTO THE CIRCULATION
Authors: PETTENGELL R LUFT T DEWYNTER E COUTINHO L YOUNG R FITZSIMMONS L SCARFFE JH TESTA NG
Citation: R. Pettengell et al., EFFECTS OF INTERLEUKIN-6 ON MOBILIZATION OF PRIMITIVE HEMATOPOIETIC-CELLS INTO THE CIRCULATION, British Journal of Haematology, 89(2), 1995, pp. 237-242
HUMAN BONE-MARROW MICROVASCULAR ENDOTHELIAL-CELLS SUPPORT LONG-TERM PROLIFERATION AND DIFFERENTIATION OF MYELOID AND MEGAKARYOCYTIC PROGENITORS
Authors: RAFII S SHAPIRO F PETTENGELL R FERRIS B NACHMAN RL MOORE MAS ASCH AS
Citation: S. Rafii et al., HUMAN BONE-MARROW MICROVASCULAR ENDOTHELIAL-CELLS SUPPORT LONG-TERM PROLIFERATION AND DIFFERENTIATION OF MYELOID AND MEGAKARYOCYTIC PROGENITORS, Blood, 86(9), 1995, pp. 3353-3363
PREFERENTIAL EXPANSION OF HEMATOPOIETIC VERSUS ACUTE MYELOID-LEUKEMIACELLS EX-VIVO
Authors: PETTENGELL R SHIDO K KANZ L BERMAN E MOORE MAS
Citation: R. Pettengell et al., PREFERENTIAL EXPANSION OF HEMATOPOIETIC VERSUS ACUTE MYELOID-LEUKEMIACELLS EX-VIVO, Blood, 86(10), 1995, pp. 568-568
HEMATOPOIETIC GROWTH-FACTORS AND DOSE INTENSITY IN HIGH-GRADE AND INTERMEDIATE-GRADE LYMPHOMA
Authors: PETTENGELL R CROWTHER D
Citation: R. Pettengell et D. Crowther, HEMATOPOIETIC GROWTH-FACTORS AND DOSE INTENSITY IN HIGH-GRADE AND INTERMEDIATE-GRADE LYMPHOMA, Annals of oncology, 5, 1994, pp. 190000133-190000141
A RELIABLE APPROACH FOR SEQUENCING CLONE-SPECIFIC CDRIII REGIONS IN B-CELL LYMPHOMA
Authors: STRAKA C PETTENGELL R PIELMEIER A CROSS M EMMERICH B CROWTHER D TESTA NG DEXTER TM
Citation: C. Straka et al., A RELIABLE APPROACH FOR SEQUENCING CLONE-SPECIFIC CDRIII REGIONS IN B-CELL LYMPHOMA, Annals of oncology, 5, 1994, pp. 190000079-190000084
RAPID IMMUNOLOGICAL RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN HIGH-GRADE NON-HODGKIN-LYMPHOMA
Authors: SCHEID C PETTENGELL R GHIELMINI M RADFORD JA MORGENSTERN GR CROWTHER D STERN PL
Citation: C. Scheid et al., RAPID IMMUNOLOGICAL RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN HIGH-GRADE NON-HODGKIN-LYMPHOMA, Experimental hematology, 22(8), 1994, pp. 781-781
VIABILITY OF HEMATOPOIETIC PROGENITORS FROM WHOLE-BLOOD, BONE-MARROW AND LEUKAPHERESIS PRODUCT - EFFECTS OF STORAGE MEDIA, TEMPERATURE AND TIME
Authors: PETTENGELL R WOLL PJ OCONNOR DA DEXTER TM TESTA NG
Citation: R. Pettengell et al., VIABILITY OF HEMATOPOIETIC PROGENITORS FROM WHOLE-BLOOD, BONE-MARROW AND LEUKAPHERESIS PRODUCT - EFFECTS OF STORAGE MEDIA, TEMPERATURE AND TIME, Bone marrow transplantation, 14(5), 1994, pp. 703-709
EFFECTS OF ERYTHROPOIETIN ON MOBILIZATION OF HEMATOPOIETIC PROGENITORCELLS
Authors: PETTENGELL R WOLL PJ CHANG J COUTINHO L TESTA NG CROWTHER D
Citation: R. Pettengell et al., EFFECTS OF ERYTHROPOIETIN ON MOBILIZATION OF HEMATOPOIETIC PROGENITORCELLS, Bone marrow transplantation, 14(1), 1994, pp. 125-130
DIRECT COMPARISON BY LIMITING DILUTION ANALYSIS OF LONG-TERM CULTURE-INITIATING CELLS IN HUMAN BONE-MARROW, UMBILICAL-CORD BLOOD, AND BLOODSTEM-CELLS
Authors: PETTENGELL R LUFT T HENSCHLER R HOWS JM DEXTER TM RYDER D TESTA NG
Citation: R. Pettengell et al., DIRECT COMPARISON BY LIMITING DILUTION ANALYSIS OF LONG-TERM CULTURE-INITIATING CELLS IN HUMAN BONE-MARROW, UMBILICAL-CORD BLOOD, AND BLOODSTEM-CELLS, Blood, 84(11), 1994, pp. 3653-3659
Risultati: 1-25 | 26-28